Screening mutation in RYR2 gene in a Kazakhstani idiopathic ventricular tachycardia study cohort: two novel mutations
dc.contributor.author | Akilzhanova, A. | |
dc.contributor.author | Guelly, C. | |
dc.contributor.author | Abilova, Z. M. | |
dc.contributor.author | Rakhimova, S. | |
dc.contributor.author | Nuralinov, O. M. | |
dc.contributor.author | Abdrakhmanov, A. C. | |
dc.contributor.author | Bekbosynova, M. S. | |
dc.date.accessioned | 2015-10-22T10:57:00Z | |
dc.date.available | 2015-10-22T10:57:00Z | |
dc.date.issued | 2014 | |
dc.description.abstract | The human ryanodine receptor 2 (RYR2) is one of the key players tightly regulating calcium efflux from the sarcoplasmic reticulum to the cytosol and found frequently mutated (<60%) in context of catecholaminergic polymorphic ventricular tachycardia (CPVT1) [1]. | ru_RU |
dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/420 | |
dc.language.iso | en | ru_RU |
dc.publisher | Nazarbayev University | ru_RU |
dc.subject | ventricular tachycardia | ru_RU |
dc.subject | ventricular arrhythmia | ru_RU |
dc.subject | RYR2 gene | ru_RU |
dc.title | Screening mutation in RYR2 gene in a Kazakhstani idiopathic ventricular tachycardia study cohort: two novel mutations | ru_RU |
dc.type | Abstract | ru_RU |